NO994049D0 - Metode for å fremstille farmasöytiske forbindelser - Google Patents
Metode for å fremstille farmasöytiske forbindelserInfo
- Publication number
- NO994049D0 NO994049D0 NO994049A NO994049A NO994049D0 NO 994049 D0 NO994049 D0 NO 994049D0 NO 994049 A NO994049 A NO 994049A NO 994049 A NO994049 A NO 994049A NO 994049 D0 NO994049 D0 NO 994049D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical compounds
- preparing pharmaceutical
- preparing
- compounds
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3911497P | 1997-02-26 | 1997-02-26 | |
| US3911697P | 1997-02-26 | 1997-02-26 | |
| PCT/US1998/003655 WO1998038158A1 (en) | 1997-02-26 | 1998-02-25 | Process for preparing pharmaceutical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994049D0 true NO994049D0 (no) | 1999-08-23 |
| NO994049L NO994049L (no) | 1999-08-23 |
Family
ID=26715826
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994049A NO994049L (no) | 1997-02-26 | 1999-08-23 | Metode for aa fremstille farmasöytiske forbindelser |
| NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6143909A (no) |
| EP (2) | EP0861838A3 (no) |
| JP (2) | JP2002512603A (no) |
| KR (2) | KR20000075671A (no) |
| CN (2) | CN1252788A (no) |
| AU (2) | AU6667198A (no) |
| BR (2) | BR9807265A (no) |
| CA (2) | CA2281104A1 (no) |
| CZ (1) | CZ9902998A3 (no) |
| EA (2) | EA199900770A1 (no) |
| ID (2) | ID22984A (no) |
| IL (2) | IL131205A0 (no) |
| NO (2) | NO994049L (no) |
| NZ (1) | NZ336918A (no) |
| PL (2) | PL335347A1 (no) |
| TR (2) | TR199902064T2 (no) |
| WO (2) | WO1998038158A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001500484A (ja) * | 1996-08-30 | 2001-01-16 | イーライ・リリー・アンド・カンパニー | 医薬化合物の製造法 |
| CA2264557A1 (en) * | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Process and novel intermediates |
| HUP0104027A3 (en) * | 1998-10-16 | 2002-08-28 | Univ Hawaii Honolulu | Stereoselective process for producing cryptophycin |
| WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
| WO2000034253A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives |
| AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| WO2005116200A2 (en) | 2004-05-05 | 2005-12-08 | Regents Of The University Of Minnesota | Nucleic acids and polypeptides involved in the production of cryptophycin |
| CN101962323B (zh) * | 2010-07-16 | 2013-06-05 | 中国人民解放军第二军医大学 | 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途 |
| CN111333560B (zh) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | 一种制备螺环β-内酰胺的方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
| US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
| US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
| US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
| CA2047191A1 (en) * | 1989-02-17 | 1990-08-18 | Hendrik M. Geysen | Method for the use and synthesis of peptides |
| US5256802A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Process for the production of oxiranes |
| WO1994011388A1 (en) * | 1992-11-06 | 1994-05-26 | Chiron Mimotopes Pty. Ltd. | Support for the synthesis of modular polymers |
| GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
| WO1995017093A1 (en) * | 1993-12-21 | 1995-06-29 | University Of Hawaii | New cryptophycins |
| US5952298A (en) * | 1993-12-21 | 1999-09-14 | The University Of Hawaii | Cryptophycins |
| DE69516415T2 (de) * | 1994-10-14 | 2000-09-14 | Stratagene, La Jolla | Porphyrin-markierung von polynukleotiden |
| EP0830136B1 (en) * | 1995-03-07 | 2004-10-20 | University Of Hawaii | New cryptophycins from synthesis |
| EA000438B1 (ru) * | 1995-03-31 | 1999-08-26 | Ниппон Кемифар Ко., Лтд. | Производные эпоксиянтарной кислоты |
| US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| WO1997007798A1 (en) * | 1995-08-30 | 1997-03-06 | Eli Lilly And Company | Pharmaceutical compounds |
| ES2194129T3 (es) * | 1995-12-22 | 2003-11-16 | Univ Hawaii | Compuestos farmaceuticos. |
| AU724312B2 (en) * | 1996-02-07 | 2000-09-14 | Buckman Laboratories International, Inc. | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same |
| WO1997031632A1 (en) * | 1996-02-27 | 1997-09-04 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1998008829A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
| AU4330097A (en) * | 1996-08-30 | 1998-03-19 | Eli Lilly And Company | Pharmaceutical compounds |
| EP0934065B1 (en) * | 1996-08-30 | 2006-06-07 | University Of Hawaii | Novel cryptophycin derivatives as anti-neoplastic agents |
| US6025506A (en) * | 1997-02-21 | 2000-02-15 | Dsm N.V. | Process for preparing an optically active phenylglycidyl acid derivative |
| IL123352A0 (en) * | 1997-02-27 | 1998-09-24 | Tanabe Seiyaku Co | Process for preparing an optically active trans-3-substituted glycidic acid ester |
-
1998
- 1998-02-25 IL IL13120598A patent/IL131205A0/xx unknown
- 1998-02-25 CZ CZ19992998A patent/CZ9902998A3/cs unknown
- 1998-02-25 EP EP98301367A patent/EP0861838A3/en not_active Withdrawn
- 1998-02-25 BR BR9807265-0A patent/BR9807265A/pt unknown
- 1998-02-25 CN CN98804250A patent/CN1252788A/zh active Pending
- 1998-02-25 BR BR9811252-0A patent/BR9811252A/pt not_active IP Right Cessation
- 1998-02-25 EA EA199900770A patent/EA199900770A1/ru unknown
- 1998-02-25 EP EP98301368A patent/EP0861839A1/en not_active Ceased
- 1998-02-25 IL IL13116298A patent/IL131162A0/xx unknown
- 1998-02-25 NZ NZ336918A patent/NZ336918A/en unknown
- 1998-02-25 AU AU66671/98A patent/AU6667198A/en not_active Abandoned
- 1998-02-25 CA CA002281104A patent/CA2281104A1/en not_active Abandoned
- 1998-02-25 CN CN98804251A patent/CN1255121A/zh active Pending
- 1998-02-25 CA CA002281108A patent/CA2281108A1/en not_active Abandoned
- 1998-02-25 KR KR1019997007737A patent/KR20000075671A/ko not_active Application Discontinuation
- 1998-02-25 JP JP53779998A patent/JP2002512603A/ja active Pending
- 1998-02-25 JP JP53780398A patent/JP2002513403A/ja active Pending
- 1998-02-25 ID IDW990901A patent/ID22984A/id unknown
- 1998-02-25 US US09/380,005 patent/US6143909A/en not_active Expired - Fee Related
- 1998-02-25 KR KR1019997007686A patent/KR20000075623A/ko not_active Application Discontinuation
- 1998-02-25 EA EA199900772A patent/EA002547B1/ru not_active IP Right Cessation
- 1998-02-25 ID IDW990900D patent/ID24527A/id unknown
- 1998-02-25 TR TR1999/02064T patent/TR199902064T2/xx unknown
- 1998-02-25 WO PCT/US1998/003655 patent/WO1998038158A1/en active Search and Examination
- 1998-02-25 PL PL98335347A patent/PL335347A1/xx unknown
- 1998-02-25 TR TR1999/02065T patent/TR199902065T2/xx unknown
- 1998-02-25 PL PL98335478A patent/PL335478A1/xx unknown
- 1998-02-25 AU AU66672/98A patent/AU738999B2/en not_active Ceased
- 1998-02-25 WO PCT/US1998/003667 patent/WO1998038164A1/en not_active Application Discontinuation
-
1999
- 1999-08-23 NO NO994049A patent/NO994049L/no not_active Application Discontinuation
- 1999-08-24 NO NO994083A patent/NO994083L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973518A (fi) | Farmaseuttinen koostumus piperidinoalkanoliyhdisteille | |
| PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
| NO994757L (no) | Fremgangsmåte for oral administrasjon av proteiner | |
| NO995681D0 (no) | Fremgangsmåte for å fremstille fluorbiprofen-tabletter | |
| AR017655A1 (es) | Metodo para preparar eteres de monofluormetilo | |
| NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
| NO20001728D0 (no) | Fremgangsmåte for fremstilling av chirale forbindelser | |
| ID28601A (id) | Proses penyiapan senyawa-senyawa 1,4-dihidropiridin | |
| IT1272922B (it) | Procedimento per la preparazione di composti metallocenici | |
| NO994049D0 (no) | Metode for å fremstille farmasöytiske forbindelser | |
| ID22840A (id) | Proses untuk penyiapan komposisi aspal | |
| NO995851L (no) | Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse | |
| TR199800403A3 (tr) | a-Bromo-laktam türevlerinin hazirlanmasi için yöntem. | |
| EE9800195A (et) | Uudsed analgeetilise toimega ühendid | |
| NO20001777D0 (no) | Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer | |
| NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
| ID22430A (id) | Proses pembuatan senyawa-senyawa benzotiazolona | |
| NO993863L (no) | Forbindelser og fremgangsmÕte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer | |
| EE200000401A (et) | Farmatseutilise preparaadi valmistamismeetod | |
| NO965448L (no) | Farmasöytiske forbindelser | |
| NO20003145D0 (no) | FremgangsmÕte for fremstilling av paroxetine-hydroklorid | |
| NO980316D0 (no) | Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam | |
| EG21226A (en) | Process for preparing of new pharmaceutical compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |